Welcome to the Dr Reddys Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Dr. Reddy's Laboratories Ltd. closed 9.65% below its 52-week high of 1,404.60 rupees, which the company reached on January 8th.

Dr. Reddy's Laboratories Ltd. closed 8.90% below its 52-week high of 1,404.60 rupees, which the company achieved on January ...

Dr Reddy’s Laboratories ( ($RDY) ) has provided an update. On December 23, 2025, Dr. Reddy’s Laboratories announced that its Board of Directors ...

Dr. Reddy's Laboratories reports impressive financial results, with record-breaking sales and profitability in their recent quarter. The company shows strong growth in their India, North America, ...

SHREVEPORT, La. (KTAL/KMSS) – Dr. Reddy’s Laboratories, a global pharmaceutical company, recently closed in early 2025 due to business and financial decisions. U.S. Senator Bill Cassidy, M.D. (R-LA), ...

Dr Reddy’s Laboratories ( ($RDY) ) just unveiled an update. On December 12, 2025, Dr. Reddy’s Laboratories announced that the United States Food & ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

The Delhi High Court refused to stop an earlier order that lets Dr Reddy's make Semaglutide in India only for export, saying Novo Nordisk's patent challenge needs a full hearing before any decision ...

Dr. Reddy's Lab is undervalued due to exaggerated concerns about Revlimid revenue decline and the underappreciated potential of new high-growth products like biosimilars and GLP-1 drugs. Despite the ...

Motilal Oswal recommended Neutral rating on Dr Reddys Labs with a target price of Rs 1250 in its research report dated ...